Capital International LTD Astrazeneca PLC Transaction History

Capital International LTD

$2.09 Billion
Q2 2024

A detailed history of Capital International LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital International LTD holds 38,956 shares of AZN stock, worth $3.06 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

38,956

Previous 43,620 10.69%

Holding current value

$3.06 Million

Previous $2.96 Million 2.81%

% of portfolio

0.15%

Previous 0.15%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $311,601 - $376,991	-4,664 Reduced 10.69%	38,956 $3.04 Million
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $46,321 - $52,803	759 Added 1.77%	43,620 $2.96 Million
Q4 2023 Feb 13, 2024	SELL	$61.89 - $69.28 $189,507 - $212,135	-3,062 Reduced 6.67%	42,861 $2.89 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $18,871 - $20,864	-291 Reduced 0.63%	45,923 $3.11 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $190,270 - $215,730	3,013 Added 6.97%	46,214 $3.21 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $640,599 - $832,389	11,817 Added 37.65%	43,201 $2.93 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $842,540 - $2.16 Million	15,891 Added 102.57%	31,384 $1.72 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $918,115 - $1.1 Million	15,493 New	15,493 $1.02 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $941,727 - $1.08 Million	-17,745 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $2.34 Million - $3.01 Million	-54,400 Reduced 75.4%	17,745 $939,000
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $822,121 - $1.12 Million	-21,755 Reduced 23.17%	72,145 $3.22 Million
Q4 2019 Feb 18, 2020	SELL	$42.46 - $50.46 $50,952 - $60,552	-1,200 Reduced 1.26%	93,900 $4.68 Million
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $178,944 - $200,064	-4,800 Reduced 4.8%	95,100 $3.93 Million
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $102,921 - $124,758	2,900 Added 2.99%	99,900 $4.04 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $1.39 Million - $1.57 Million	37,800 Added 63.85%	97,000 $3.68 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $58,734 - $62,984	-1,700 Reduced 2.79%	59,200 $2.08 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $39,564 - $43,956	-1,200 Reduced 1.93%	60,900 $2.13 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $1.8 Million - $2.11 Million	62,100	62,100 $2.1 Million

Others Institutions Holding AZN

# of Institutions

1,332

Shares Held

490M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $243B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

News

Stay updated on Capital International LTD with notifications on news.

Account

Capital International LTD Astrazeneca PLC Transaction History